Seminar 04 June 2025 - Feasibility and economics of improved child deworming with albendazole-ivermectin

The BRCCH cordially invites you to join our seminar about feasibility and economics of improved child deworming.
When: Wednesday, 4th June 2025, 16:00 - 18:00 CET
Where: Seminar room 4– Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil
Registration: HERE
Directions and location information
Schedule:
-
-
- Prof Jennifer Keiser, Prof Peter Steinmann, Prof Fabrizio Tediosi (all Swiss TPH) "Feasibility and economics of improved child deworming with albendazole-ivermectin"
- Q&A and Closing
-
Speakers:

Prof Jennifer Keiser
Swiss TPH, Allschwil, Switzerland
Prof Jennifer Keiser heads the Helminth Drug Development Unit at Swiss TPH, which maintains a large and unique set of helminth-rodent models. She is also a Professor of Neglected Tropical Diseases in the Faculty of Science at the University of Basel. Her team’s research objectives include in vitro and in vivo evaluations of the biological activities of chemical compounds, assay development, preclinical studies such as pharmacokinetics and metabolism and clinical trials in helminthiasis-endemic countries, particularly in Côte d’Ivoire, the Lao People’s Democratic Republic, Russia and Tanzania. Prof Keiser holds a five-year ERC Advanced Grant and is leading a five-year multi-partner EU grant to develop new drugs against neglected helminth infections.
Prof Jennifer Keiser leads the BRCCH project: FACEIT: Feasibility and Economic Evaluation of Improved Child Deworming. Read more here.

Prof Peter Steinmann
Swiss TPH, Allschwil, Switzerland
Dr Peter Steinmann is a trained epidemiologist and public health specialist and holds a habilitation (associate professorship) at the University of Basel. His research interests include the epidemiology and sustainable control of intestinal helminth and schistosome infections; the impact of intestinal parasite infections on child health, nutrition and well-being; the transmission of Mycobacterium leprae and post-exposure prophylaxis for contact and the elimination and eradication of neglected tropical diseases (NTDs). He has a track record of work related to NTDs and public health in over two dozen countries over the last 15 years, including four years in China. He is currently deputy head of unit. His technical expertise includes NTD research and control programme implementation in China, Central and South-East Asia, Africa and Brazil, public health, WASH, health systems, data quality and surveillance and epidemiological surveys.
Prof Peter Steinmann co- leads the BRCCH project: FACEIT: Feasibility and Economic Evaluation of Improved Child Deworming. Read more here.

Prof Fabrizio Tediosi
Swiss TPH, Allschwil, Switzerland
Prof Fabrizio Tediosi leads the Health Systems and Policies group in the Department of Epidemiology and Public Health at the Swiss Tropical and Public Health Institute (Swiss TPH) and is a professor at the University of Basel. He holds a degree in economics and management from the University of Pavia, Italy, an MSc in health economics from the University of York, UK and a PhD in international public health from the University of Basel. He is an economist specializing in health policy analysis, the economic evaluation of priority setting, healthcare costing, the organization and financing of health systems, the economics of drugs, the economics of ageing and international development cooperation. His research interests also include universal health coverage, the economic and social implications of the elimination and eradication of neglected tropical diseases and global health governance.
Prof Fabrizio Tediosi co- leads the BRCCH project: FACEIT: Feasibility and Economic Evaluation of Improved Child Deworming. Read more here.